GI & Endoscopy

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 31 to Aug. 4.

Christopher Kulisek, MD, is a gastroenterologist and the founder of Knoxville, Tenn.-based West Knox Gastroenterology.

RD Biomed registered its reflux disease testing device Peptest with the FDA, Inside Media Limited reports.

The Independent Data Monitoring Committee completed a planned analysis of the first half of Celsion's phase III study of ThermoDox, its liver cancer drug.

The European Commission awarded Bayer marketing authorization for its second line liver cancer treatment Stivarga, Pipeline Review.com reports.

The single specialty gastroenterology and hepatology practice Gastro Group & EndoCenter has been serving Slidell and Covington, La. for more than 30 years.

Anthony Albright, MD, is a gastroenterologist at Covington, La.-based Gastro Group & EndoCenter.

Ironwood Pharmaceuticals reported second quarter fiscal year 2017 revenues of $65.1 billion, Nasdaq reports.

The National institute of Diabetes and Digestive and Kidney Diseases awarded Tucson-based University of Arizona Steele Children's Research Center a five-year, $1.9 million grant to study how NHE8 proteins affect inflammatory bowel disease and colon cancer developments.

Hepatitis C patients who treated infections with direct-acting antiviral agents still face a reinfection risk, according to MedPage Today.